Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.094 | 0.4 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |